Found: 28
Select item for more details and to access through your institution.
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
- Published in:
- 2004
- By:
- Publication type:
- journal article
A Bayesian adaptive design for estimating the maximum tolerated dose curve using drug combinations in cancer phase I clinical trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vascular Endothelial Growth Factor and Soft Tissue Sarcomas: Tumor Expression Correlates With Grade.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2001, v. 8, n. 3, p. 260, doi. 10.1007/s10434-001-0260-9
- By:
- Publication type:
- Article
Escalation with Overdose Control Using Time to Toxicity for Cancer Phase I Clinical Trials.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0093070
- By:
- Publication type:
- Article
Statistical assessment of multivalued screening tests.
- Published in:
- Canadian Journal of Statistics, 1998, v. 26, n. 4, p. 657, doi. 10.2307/3315724
- By:
- Publication type:
- Article
Combined Quantitative Assessment of Myocardial Perfusion and Coronary Artery Calcium Score by Hybrid <sup>82</sup>Rb PET/CT Improves Detection of Coronary Artery Disease.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1345, doi. 10.2967/jnumed.114.153429
- By:
- Publication type:
- Article
Number of Patients per Cohort and Sample Size Considerations Using Dose Escalation with Overdose Control.
- Published in:
- Journal of Probability & Statistics, 2012, p. 1, doi. 10.1155/2012/692725
- By:
- Publication type:
- Article
Incorporating a Patient Dichotomous Characteristic in Cancer Phase I Clinical Trials Using Escalation with Overdose Control.
- Published in:
- Journal of Probability & Statistics, 2012, p. 1, doi. 10.1155/2012/567819
- By:
- Publication type:
- Article
Escalation with Overdose Control Using Ordinal Toxicity Grades for Cancer Phase I Clinical Trials.
- Published in:
- Journal of Probability & Statistics, 2012, p. 1, doi. 10.1155/2012/317634
- By:
- Publication type:
- Article
Statistical Concepts and Applications in Clinical Medicine. John Aitchison, Jim W. Kay and Ian J. Lauder, Chapman Hall/CRC, Boca Raton, 2005. No. of pages: 339. Price: $79.95. ISBN 1-58488-208-5.
- Published in:
- Statistics in Medicine, 2007, v. 26, n. 4, p. 943, doi. 10.1002/sim.2541
- By:
- Publication type:
- Article
Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control.
- Published in:
- Statistics in Medicine, 2005, v. 24, n. 14, p. 2183, doi. 10.1002/sim.2106
- By:
- Publication type:
- Article
Dose Finding in Oncology Trials Guided by Ordinal Toxicity Grades Using Continuous Dose Levels.
- Published in:
- Entropy, 2024, v. 26, n. 8, p. 687, doi. 10.3390/e26080687
- By:
- Publication type:
- Article
Escalation with Overdose Control is More Efficient and Safer than Accelerated Titration for Dose Finding.
- Published in:
- Entropy, 2015, v. 17, n. 8, p. 5288, doi. 10.3390/e17085288
- By:
- Publication type:
- Article
Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30.
- Published in:
- NPJ Breast Cancer, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41523-022-00489-9
- By:
- Publication type:
- Article
Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data.
- Published in:
- Quality of Life Research, 2023, v. 32, n. 3, p. 827, doi. 10.1007/s11136-022-03267-z
- By:
- Publication type:
- Article
A multi-laboratory preclinical trial in rodents to assess treatment candidates for acute ischemic stroke.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 714, p. 1, doi. 10.1126/scitranslmed.adg8656
- By:
- Publication type:
- Article
Comparison between continuous and discrete doses for model based designs in cancer dose finding.
- Published in:
- PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0210139
- By:
- Publication type:
- Article
A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve.
- Published in:
- European Heart Journal, 2016, v. 37, n. 19, p. 1504, doi. 10.1093/eurheartj/ehv647
- By:
- Publication type:
- Article
On the properties of the toxicity index and its statistical efficiency.
- Published in:
- Statistics in Medicine, 2021, v. 40, n. 6, p. 1535, doi. 10.1002/sim.8858
- By:
- Publication type:
- Article
Dose finding with drug combinations in cancer phase I clinical trials using conditional escalation with overdose control.
- Published in:
- Statistics in Medicine, 2014, v. 33, n. 22, p. 3815, doi. 10.1002/sim.6201
- By:
- Publication type:
- Article
Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 17, p. 3233, doi. 10.1002/cncr.34341
- By:
- Publication type:
- Article
A NEUTROSOPHIC DESCRIPTION LOGIC.
- Published in:
- New Mathematics & Natural Computation, 2008, v. 4, n. 3, p. 273, doi. 10.1142/S1793005708001100
- By:
- Publication type:
- Article
Constructing meiotic maps with known error probability.
- Published in:
- Genetic Epidemiology, 1999, v. 16, n. 3, p. 274, doi. 10.1002/(SICI)1098-2272(1999)16:3<274::AID-GEPI4>3.0.CO;2-D
- By:
- Publication type:
- Article
Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Patient-Specific Dose Adjustment in the Cancer Clinical Trial Setting.
- Published in:
- Pharmaceutical Medicine, 2008, v. 22, n. 6, p. 345, doi. 10.1007/BF03256730
- By:
- Publication type:
- Article
Patient specific dosing in a cancer phase I clinical trial.
- Published in:
- Statistics in Medicine, 2001, v. 20, n. 14, p. 2079, doi. 10.1002/sim.848
- By:
- Publication type:
- Article
Radioimmunotherapy of Non-Hodgkin's Lymphoma with <sup>90</sup>Y-DOTA Humanized Anti-CD22 IgG (<sup>90</sup>Y-Epratuzumab): Do Tumor Targeting and Dosimetry Predict Therapeutic Response?
- Published in:
- Journal of Nuclear Medicine, 2003, v. 44, n. 12, p. 2000
- By:
- Publication type:
- Article
Visualizing adverse events in clinical trials using correspondence analysis with R-package visae.
- Published in:
- 2021
- By:
- Publication type:
- journal article